Khoo JP, Stein D, Ameringen MV, Hoschl C, et al. Efficacy and safety of agomelatine 25-50 mg/day versus escitalopram 10-20 mg/day in severe generalised anxiety disorder. BIPOLAR DISORDERS, 2019, Vol. 21, S1: 135-135 Meeting Abstract: P-166

16. 4. 2019


Khoo JP, Stein D, Ameringen MV, Hoschl C, Ahokas A, Bauer M, Bitter I, Jarema M, Mosolov SN, Vavrusova L, Picarel-Blanchot F, Olivier V, de Bodinat C. Efficacy and safety of agomelatine 25-50 mg/day versus escitalopram 10-20 mg/day in severe generalised anxiety disorder. Conference: 21st Annual ISBD Conference on Global Advances in Bipolar Disorder and Depression Location: Sydney, AUSTRALIA Date: MAR 20-23, 2019
Sponsor(s): ISBD
BIPOLAR DISORDERS, Volume: 21, Special Issue: SI Supplement: 1 Pages: 135-135 Meeting Abstract: P-166